EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy

Konstantinos Venetis, Carlo Pescia, Giulia Cursano, Chiara Frascarelli, Eltjona Mane iD, Elisa De Camilli iD, Elisabetta Munzone iD, Silvia Dellapasqua, Carmen Criscitiello iD, Giuseppe Curigliano iD, Elena Guerini Rocco, Nicola Fusco iD

International Journal of Molecular Sciences · 24.05.2024 · 25 (11) · 5717

DOI: 10.3390/ijms25115717 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.05.2024. Verfasst von Konstantinos Venetis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Genomics. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multigene prognostic genomic assays have become indispensable in managing early breast cancer (EBC), offering crucial information for risk stratification and guiding adjuvant treatment strategies in conjunction with traditional clinicopathological parameters. The American Society of Clinical Oncology (ASCO) guidelines endorse these assays, though some clinical contexts still lack definitive recommendations. The dynamic landscape of EBC management demands further refinement and optimization of genomic assays to streamline their incorporation into clinical practice. The breast cancer community is poised at the brink of transformative advances in enhancing the clinical utility of genomic assays, aiming to significantly improve the precision and effectiveness of both diagnosis and treatment for women with EBC. This article methodically examines the testing methodologies, clinical validity and utility, costs, diagnostic frameworks, and methodologies of the established genomic tests, including the Oncotype Dx Breast Recurrence Score®, MammaPrint, Prosigna®, EndoPredict®, and Breast Cancer Index (BCI). Among these tests, Prosigna and EndoPredict® have at present been validated only on a prognostic level, while Oncotype Dx, MammaPrint, and BCI hold both a prognostic and predictive role. Oncologists and pathologists engaged in the management of EBC will find in this review a thorough comparison of available genomic assays, as well as strategies to optimize the utilization of the information derived from them.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGenomicsHumansFemalePrognosisBiomarkers, TumorGenetic Testing

Stichwörter der Autor:innen

adjuvant chemotherapyearly breast cancerendocrine therapygenomic testingprognosticationrisk assessment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • School of Pathology, University of Milan, 20122 Milan, Italy.
  • Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
  • Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Division of New Drugs and Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

ORCID-Profile: Eltjona Mane, Elisa De Camilli, Elisabetta Munzone, Carmen Criscitiello, Giuseppe Curigliano, Nicola Fusco

Zitieren

APA

Venetis, K., Pescia, C., Cursano, G., Frascarelli, C., Mane, E., De Camilli, E., Munzone, E., Dellapasqua, S., Criscitiello, C., Curigliano, G., Guerini Rocco, E., & Fusco, N. (2024). The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy. International Journal of Molecular Sciences, 25(11), 5717. https://doi.org/10.3390/ijms25115717

Vancouver

Venetis K, Pescia C, Cursano G, Frascarelli C, Mane E, De Camilli E, et al. The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy. International Journal of Molecular Sciences. 2024;25(11):5717. doi:10.3390/ijms25115717

BibTeX
@article{Venetis2024,
  author = {Venetis, Konstantinos and Pescia, Carlo and Cursano, Giulia and Frascarelli, Chiara and Mane, Eltjona and De Camilli, Elisa and Munzone, Elisabetta and Dellapasqua, Silvia and Criscitiello, Carmen and Curigliano, Giuseppe and Guerini Rocco, Elena and Fusco, Nicola},
  title = {The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {11},
  pages = {5717},
  doi = {10.3390/ijms25115717}
}
Kostenlos starten →